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Abstract: Synthetic biology brings engineering disciplines to create novel biological systems for 
biomedical and technological applications. The substantial growth of the synthetic biology field in 
the past decade is poised to transform biotechnology and medicine. To streamline design processes 
and facilitate debugging of complex synthetic circuits, cell-free synthetic biology approaches has 
reached broad research communities both in academia and industry. By recapitulating gene 
expression systems in vitro, cell-free expression systems offer flexibility to explore beyond the 
confines of living cells and allow networking of synthetic and natural systems. Here, we review the 
capabilities of the current cell-free platforms, focusing on nucleic acid-based molecular programs 
and circuit construction. We survey the recent developments including cell-free transcription–
translation platforms, DNA nanostructures and circuits, and novel classes of riboregulators. The 
links to mathematical models and the prospects of cell-free synthetic biology platforms will also be 
discussed. 
Keywords: synthetic biology; cell-free transcription-translation; rapid prototyping; artificial cell; 
riboregulator; DNA origami; mathematical model 
 
1. Introduction 
Synthetic biology focuses on engineering biological circuits to manipulate biological systems 
and technological applications. Formative works in synthetic biology demonstrated the creation of 
simple regulatory circuits in Escherichia coli [1,2]. The dynamics of these synthetic circuits were 
reasonably captured through mathematical modeling, driving further developments of forward-
engineering approaches [3]. As the scope of synthetic biological circuits increases dramatically, 
comprehensive design, analysis, and predictive modeling in cellular contexts becomes challenging 
despite progress in computer-aided designs [4,5]. Cell-free synthetic biology provides a paradigm to 
test components and circuits in a well-controlled environment that is similar to physiological 
conditions [6]. Cell-free approaches could expedite development and exploration of synthetic system 
designs beyond the confines of living organisms. In turn, novel, sustainable, and cost-effective 
technologies based on cell-free synthetic biology could help meet broader, worldwide challenges in 
the future. 
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In this article, we review the current scope of cell-free synthetic biology, focusing on synthetic 
circuits and systems using nucleic acid-based programs. We limit ourselves to the design and 
applications of these synthetic molecular circuits. Readers are referred to other excellent reviews for 
recent developments in other areas of cell-free synthetic biology such as cell-free metabolic 
engineering [7,8]. We first survey cell-free transcription–translation platforms that are gaining 
popularity as a testbed for rapid prototyping of synthetic circuit elements and circuitry. We then 
review in vitro model dynamical systems and recent progress in de novo-designed RNA regulatory 
toolkits for synthetic biology. Next, we discuss synthetic cell approaches through 
compartmentalization and the prospect of nucleic acid-based nanostructures and circuits to function 
in cell-like environments. Finally, we discuss modeling approaches and developments as well as their 
links with the future of synthetic biological circuits. 
2. Cell-Free Transcription–Translation Platform for Synthetic Biology 
Synthetic biology approaches for achieving novel and complex functionality in cellular systems 
have shown significant progress. Using cells as chassis to engineer circuits, however, presents 
challenges for rapid design–build–test cycles despite ongoing development of applicable tools. The 
cell-free transcription–translation system presents an attractive alternative to construct, characterize, 
and interrogate synthetic biological circuits (Figure 1). Although a number of cell-free expression 
systems have been developed, including rabbit reticulocytes, wheat germ, and insect cells, the 
prokaryotic extract cell-free expression system is the most popular and is commercially available [9]. 
We will mainly discuss the E. coli cell-extract system, termed as ‘TXTL’ in this section [10]. Compared 
to in vivo systems, the cell-free TXTL platform enables rapid prototyping of genetic circuit design 
using either generic plasmid DNA templates or short linear DNA templates [11,12]. Further, because 
TXTL-based circuits are implemented in vitro, these circuits are not limited by production of toxic 
proteins and chemicals or use of unnatural amino acids, which limit implementation of the same 
circuits in living cells [13,14]. 
 
Figure 1. Overview of the cell-free transcription–translation platform. The cell-free transcription–
translation platform including Escherichia coli cell-extract (TXTL) system and PURE system, allows for 
the prototyping of synthetic circuits rapidly through iterative cycles of experiments and 
computational modeling. TXTL has a number of applications, such as characterization of CRISPR 
elements or construction of synthetic cells. Reproduced with permission from [15,16]. 
The TXTL platform is not without limitations and challenges. Energy sources can be easily 
depleted in batch mode [17], while enzymes can degrade nucleic acids and protein products within 
the cell extract. Additionally, a complete understanding of machinery in TXTL system has yet to be 
achieved, and the yields of TXTL systems can be less than yields of corresponding in vivo systems 
[6]. Molecular crowding effects [18] or unintentional crosstalk between components [19] could 
contribute to these issues. 
The PURE system is a completely purified cell-free expression platform containing the T7 RNA 
polymerase (RNAP) with fewer active components than cell extract-based TXTL systems [20]. In 
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principle, the concentration of individual components can be adjusted in the PURE system during 
reconstitution, and purification of output proteins is straightforward by using affinity 
chromatography. The PURE system is costly and typically has a smaller yield than TXTL, but it can 
be advantageous for applications that require clear background and long-term storage of genetic 
elements [21]. 
The unique advantages of cell-free reactions make TXTL an ideal platform for prototyping 
genetic circuits by characterizing the properties and activities of circuit components [22]. For instance, 
the behaviors of CRISPR components (gRNA, protospacer adjacent motif (PAM) sequence, Cas9, and 
inhibitors of Cas9) are characterized using TXTL [23]. Importantly, the design–build–test cycle can be 
performed much faster than in vivo systems, thereby facilitating rapid prototyping of engineered 
circuits [24–26]. Circuit elements characterized in TXTL can be ported to an in vivo system, as 
demonstrated by the three- and five-node oscillator systems characterized in TXTL and successfully 
ported to E. coli [27]. 
Early works by Noireaux and colleagues demonstrated a multistage cascade circuit by 
superimposing several basic (input–parameter–output) units [11], where bacteriophage RNAP drove 
the expression of cascade circuits. However, with cascades including three to five stages, circuit 
performance was limited because of simple regulatory structures and extensive resource utilization. 
To expand the repertoire of transcriptional regulatory elements, sigma factors and cognate E. coli 
promoters were used for circuit construction [10,22]. They were able to demonstrate a five-stage 
transcriptional activation cascade through clever use of the different affinities of sigma factors to the 
core RNAP for efficient signal propagation (Figure 2A, left). Regulatory functions can be expanded 
by integrating various regulatory elements for constructing a more complex circuit (Figure 2A, right). 
Simultaneously monitoring the concentrations of produced RNA and proteins can assist in 
debugging synthetic circuits characterized in TXTL [19]. 
Synthetic RNA circuits are also efficiently and easily characterized in TXTL. Networks 
constructed from riboregulators propagate signals directly as RNAs, thus bypassing intermediate 
proteins, making these networks potentially simpler to design and implement than transcription 
factor-based layered circuits [28]. qPCR and next-generation sequencing techniques can characterize 
species, structural states, and interactions of RNAs [29]. Since the speed of signal propagation within 
circuits is determined by the decay rate of the signal, RNA networks can operate on much faster time 
scales than protein networks [30]. An early model of an RNA circuit used the transcriptional 
attenuator structure of RNA and its complementary antisense RNA [28]. The hairpin structure of the 
transcriptional attenuator was targeted by antisense RNA, which promoted the formation of a 
downstream intrinsic terminator hairpin that caused RNAP to fall off and stop transcription (Figure 
2B). Other simple RNA-based circuits have also been characterized in TXTL systems [26,31], such as 
a negative autoregulation circuits, which use the attenuator and antisense RNA simultaneously [32]. 
The strength of the TXTL platform enables the expression of remarkably large natural DNA 
programs. A large amplification of the T7 phage, with a genome size of 40 kbp and supplemented 
with thioredoxin, was observed in vitro [33]. Cell-free self-organization of the even larger T4 phage, 
with a genome size of 169 kbp, under in vitro conditions was observed by increasing molecular 
crowding effects [34]. Replication of viral genomes occurred simultaneously with phage gene 
expression, protein synthesis, and viral assembly. 
Beyond scientific inquiry, several practical tools emerged for using cell-free expression 
platforms. For instance, sequence-specific colorimetric detection of Zika viral RNA can be performed 
at single-base resolutions through a cell-free reaction on a paper disc. This paper-based diagnostic 
platform is advantageous because it is mobile and low-cost [35]. Another recent development 
demonstrated microfluidic reactors [15] and paper-based devices [36] that produced therapeutic 
proteins on demand. 
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Figure 2. Systematic construction of DNA and RNA circuitry in TXTL. (A) Basic (input–parameter–
output) modules are integrated to build complex synthetic circuits. Assembly of an AND gate, 
repressor, and inducer modules provides versatile and scalable circuits for synthetic biology 
applications. (B) RNA regulatory motifs are utilized for synthetic circuits such as a serial RNA circuit 
and a negative autoregulation circuit (NAR). The RNA circuits can be optimized in TXTL and ported 
to in vivo conditions. 
3. In Vitro Synthetic Gene Circuits 
In vitro regulatory networks are model systems that offer a flexible test bed for the design 
principles of biochemical networks without the complexity of cellular environments. In vitro 
regulatory models can be stripped of cellular machinery for protein translation and may use nucleic 
acid-based programs to design biochemical networks. In this section we will discuss simplified in 
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vitro synthetic regulatory models using the synthetic transcription-based genelet system as an 
example [37]. 
Genelets are synthetic DNA switches that form a partially double-stranded (ds) DNA template. 
The expression states of a genelet are controlled by specific DNA inputs, which are recognized by an 
incomplete promoter region in the template [38–40]. The genelet system consists of synthetic DNA 
templates and two enzymes: T7 RNAP and E. coli ribonuclease H (RNase H). Because of the 
incomplete, partially single-stranded (ss) promoter region of genelets, the DNA template (‘T’) by 
itself is poorly transcribed [41]. An ssDNA activator (‘A’) can bind to complete the promoter region, 
and the resulting complex (‘T-A’) transcribes well, approximately half as efficiently as a full dsDNA 
template [39]. The activity of genelets can be controlled by nucleic acid inputs forming an inhibitory 
regulation [39] and an excitatory regulation [42]. The inhibitable switch is turned off by an RNA 
inhibitor that binds to DNA activator more favorably than the switch template thereby removing the 
activator from the template (Figure 3A). The activating switch is turned on by an RNA activator that 
binds to a DNA inhibitor and releases the DNA activator (Figure 3B). Both the DNA inhibitor and 
activator contain a ‘toehold’, a single-stranded overhang, to facilitate toehold-mediated strand 
displacement reactions [43]. Genelet circuits have the advantages of modularity and programmability 
for switch parameters, such as concentrations of switches and activators, which are analogues of 
weights and thresholds of neurons in artificial neural networks [38]. 
 
Figure 3. Genelet switches and circuits. (A) Design and operation mechanism of an inhibitable switch. 
The input, RNA inhibitor, sequesters the DNA activator from the active template and turns the switch 
to an OFF state. (B) Design and operation mechanism of an activating switch. The input, RNA 
activator, strips off DNA inhibitor bound to DNA activator. The released DNA activator in turn can 
turn the switch to an ON state. The sequence domains are color coded to indicate identical or 
complementary sequences. (C) Schematics of bistable circuits. A single switch with positive 
autoregulation (left) or two mutually inhibiting switches (right) can show bistability. (D) Schematics 
of oscillators. An activating switch and an inhibiting switch (Design I), Design I with further positive-
autoregulation (Design II), and three inhibiting switches in a ring (Design III) form an overall negative 
feedback to achieve oscillation. Reproduced with permission from [15,16]. 
A bistable network is a dynamic system with two distinct stable equilibrium states [44], and it is 
often found in cellular networks requiring decision making processes such as cell cycle regulation, 
cellular differentiation [45], and apoptosis. The bistable network can be designed by genelets in two 
ways [39,42]: two switches can be connected in a mutually inhibiting configuration, or a single switch 
can be connected to activate its own transcription (Figure 3C). An oscillator circuit that produces 
periodic signals is another hallmark of basic circuit elements, and it is often found in cell signaling 
systems including genetic oscillation [46,47]. A synthetic oscillator was constructed using genelets 
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with three different designs [48] (Figure 3D): a two-switch negative feedback oscillator that utilized 
activating and inhibiting connections (Design I); an amplified negative feedback oscillator that 
included an additional self-activating connection (Design II); and a three-switch ring oscillator with 
three inhibitory connections (Design III). The three designs shared the same basic architecture of 
overall negative feedback in the system. An amplified negative feedback oscillator (Design II) could 
potentially have four different phases, unlike a simpler oscillator (Design I), and the ring oscillator 
with an extra connection (Design III) featured a slower oscillation. The ability to construct different 
circuit motifs using genelets demonstrated the modularity and programmability of the system 
design. However, it remains a challenge to maintain circuit operation, such as oscillation, for an 
extended period of time in batch mode because of the exhaustion of nucleoside triphosphate (NTP) 
fuel, loss of enzyme activities, and build-up of incomplete RNA transcripts [48]. 
In addition to providing basic motifs, these synthetic circuits could be coupled with downstream 
processes to dynamically control other molecular systems. A number of downstream processes, 
which can be considered as a downstream ‘load’, have been demonstrated including DNA-based 
nanomechanical devices (“DNA tweezers”) and functional RNA molecules (“aptamers”) [40] (Figure 
4A). DNA tweezers have two rigid double-stranded “arms” connected by a single-stranded hinge, 
which can be opened and closed by nucleic acid inputs. Retroactivity of the load process degraded 
the upstream oscillator circuit, which was alleviated by introducing insulator circuits to prevent 
excessive consumption of core oscillator components and to amplify RNA signals. 
 
Figure 4. Extension of genelet circuits. (A) Driving downstream processes with genelet circuits. The 
output signal from genelet circuits can be functional RNA aptamers or can be used to drive DNA 
nanodevices such as DNA tweezers. (B) Signal propagation using encapsulated genelet circuits. Each 
droplet contains a genelet switch and aptamer-activator complex. Signal molecule (DFHBI) binds the 
aptamer and releases the DNA activator for the genelet switch. The activated genelet in turn produces 
kleptamer that binds the aptamer, releases DFHBI, and attenuates fluorescence output. (C) The 
experimental fluorescence images for one- and two-dimensional signal propagation. Reproduced 
with permission from [15,16]. 
Aptamers are nucleic acid molecules that fold into complex 3D shapes and bind to specific 
targets [49]. Functional RNA aptamers can be generated in vitro and tailored for a specific target, 
which are attractive features as downstream components to be controlled by genelet circuits. For 
instance, the transcription process can be monitored by using the aptamer against chromophore 
malachite green (MG) [40]. Sensing of specific molecules is enabled by designing the activator 
sequence of a genelet switch to bind to a specific aptamer, where the recognition of analyte by its 
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aptamer releases the previously occupied DNA activator to activate the genelet. Using this approach, 
Dupin and Simmel demonstrated a genelet system to detect signal propagation in one and two 
dimensional array of compartments [50] (Figure 4B,C). The activity of enzymes can be controlled by 
using aptamers against T7 and SP6 RNAP, and an ssRNA/ssDNA with the complementary sequence 
of the aptamer, termed kleptamer, to provide yet another building block for synthetic biological 
circuitry with genelets [51]. These RNAP aptamers can also be used for logic circuits and 
transcriptional cascades [52]. 
Systems from natural processes and engineering disciplines provide further directions for 
developing genelet systems. Inspired by the architecture of electronic flip-flops, a genelet system 
design was proposed where the periods of a molecular clock were multiplied and divided [53]. 
Negative autoregulation provided model circuitry to produce outputs suitable for variable demands 
[54]. Adaptation in biological systems provided a framework to develop genelet circuits that detected 
fold-change of inputs [55]. Further, molecular titration utilized in natural and synthetic biological 
circuitry could be reiterated in genelet circuits with the support of mathematical modeling [56]. 
An analogous system, termed RTRACS (reverse transcription and transcription-based 
autonomous computing system), that relied on reverse transcriptase, DNA polymerase, RNAP, and 
RNase demonstrated modularity and programmability [57,58]. The modules of RTRACS received 
specific RNA input sequences and produced an RNA output through programmed computation. 
Experimental operation of an AND gate was demonstrated with RTRACS, and the prospect of more 
complex functionality such as oscillations was reported. The polymerase exonuclease nickase (PEN) 
toolbox bypassed the transcription step and relied exclusively on DNA and DNA-modifying 
enzymes to construct desired circuits [59,60]. Single-stranded DNA templates served as network 
architecture and short ssDNA species took the role of dynamic species that functioned as activators 
and inhibitors of templates. Despite its simplicity, the PEN toolbox successfully demonstrated 
bistability [60,61], oscillations [59,60,62], and pattern formations [63] through rational design 
approaches and easy monitoring [64]. An even more abstract approach is feasible with precisely 
programmed DNA sequences. Numerous studies demonstrated the power of DNA strand 
displacement circuits, including instructions, to create chemical reaction networks [65], logic circuits 
[66,67], neural networks [68,69], and oscillators [70] through toehold-mediated strand displacement 
[43]. These theoretical and experimental developments will enable future works to further enhance 
the programmability and complexity of synthetic in vitro circuits to control nucleic acid nanorobots 
for in vivo applications [71]. 
4. RNA Regulatory Circuits for Cell-Free Synthetic Biology 
The programmable nature of RNA molecules that allows predictable design of structure and 
function provides a rationale to construct synthetic biological circuits with RNA toolkits. The most 
basic regulatory mechanism of RNA is to induce a trans interaction between the target mRNA and 
complementary RNA; RNAs that perform this function are called riboregulators [72]. Inspired by a 
plethora of natural examples of riboregulator-based gene expression control [73], synthetic biologists 
harnessed these design principles to create synthetic riboregulators in E. coli [74]. Following these 
seminal synthetic riboregulator systems, RNA-based synthetic biological circuits have emerged that 
are easily programmable with improved performance. In this section, we will discuss the recent 
progress in synthetic RNA regulators for cell-free diagnostic applications using toehold switch and 
small transcription activating RNA (STAR) as examples. 
A toehold switch is a de novo-designed regulatory RNA inspired by the mechanism of a 
conventional engineered riboregulator [75] (Figure 5A). In the switch RNA, the ribosome binding site 
(RBS) and the start codon are blocked by its own secondary structure. When the trigger RNA is 
introduced to initiate a toehold-mediated branch migration, a switch-trigger complex is formed in 
which the RBS and the start codon become available for the expression of the target gene. In E. coli, 
high-performance toehold switches showed dynamic ranges rivaling those of well-established 
protein regulators. This suggests toehold switches can provide a novel, high-performance platform 
for synthetic biological circuits. Moreover, the RBS and the start codon are not directly involved in 
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base-pairing within the secondary structure design of switch RNA, which allows for the construction 
of a library of toehold switches without sequence constraints. 
Capitalizing the functionality of toehold switches, Pardee et al. constructed a paper-based 
diagnostic platform using a toehold switch as a sensor [21] (Figure 5B). DNA that encoded the switch 
RNA and components for cell-free expression (enzymes, dNTPs, amino acids, etc.) were freeze-dried 
on paper discs, which could remain stable for storage at room temperature. Upon the addition of the 
trigger RNA specific to toehold switches, up to 350-fold induction of green fluorescent protein (GFP) 
was observed with the desired orthogonality. This laid the foundation for development of a paper-
based diagnostic tool for Ebola virus by using toehold switches that specifically sensed part of 
nucleoprotein mRNA of Ebola as trigger RNAs [21]. β-galactosidase (LacZ) was used as a reporter 
gene to allow confirmation of results with the naked eye, and 24 toehold switches that targeted 
different sequences (Sudan strain 12 regions, Zaire strain 12 regions) were successfully tested. One 
notable feature was that the fold change of LacZ expression was dependent on the sequence of switch 
RNA, suggesting that the sequence design needed to be optimized for improved utility. In a follow-
up study, Pardee et al. constructed a paper-based diagnostic tool for Zika viruses [35]. To improve 
sensitivity, a nucleic acid sequence-based amplification (NASBA) step was introduced to 
isothermally amplify the target region of Zika RNA. Their system responded normally to Zika virus 
but not to the closely related Dengue virus. In addition, they combined this system with a 
CRISPR/Cas9-based module to create a NASBA-CRISPR cleavage (NASBACC) system. This 
biosensor showed sophisticated diagnostic performance that could discriminate strains of Zika 
viruses (American or African) by utilizing the presence of the PAM sequence. In another recent work, 
Ma et al. demonstrated a paper-based cell-free diagnostic system that detected Norovirus with 
toehold switches [76] (Figure 5B). They introduced virus enrichment via synbody and α-
complementation of LacZ enzyme to improve the sensitivity and speed of diagnosis. Takahashi et al. 
demonstrated a microbiota sensing system, rather than a single virus, with the same platform [77]. 
They designed switch RNAs based on the 16S rRNA sequence of each bacterial species, and 
functionality of the sensor was verified against 10 different bacterial strains. Moreover, they proposed 
the potential for paper-based diagnosis of more diverse target RNAs, including host biomarker 
mRNAs such as calprotectin, Interleukin 8, C-X-C motif chemokine ligand 5, oncostatin M, and 
specific pathogen toxin mRNA. These demonstrations provide evidence that toehold switches can be 
utilized as a generalizable platform for portable diagnostic systems in field testing diseases and other 
environmental samples. 
 
Figure 5. Toehold switch mechanism and application for paper-based diagnostics. (A) Mechanism of 
toehold switch. Linear-linear interaction between switch RNA and trigger RNA initiates from the 
toehold region. The resulting conformation of switch-trigger complex makes ribosome binding site 
(RBS) and start codon (AUG) available for ribosome access. (B) Freeze-dried paper-based diagnostic 
kit using toehold switch as a synthetic sensor. LacZ was used as a reporter gene so that the change of 
color could be checked by the naked eye. 
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To process an increasing complexity of inputs through synthetic biological circuitry, it is 
necessary to integrate a number of input signals in a seamless manner. To achieve this goal, the basic 
mechanism of the toehold switch has been expanded to incorporate multiple toehold switches in the 
same RNA transcript, which facilitates signal integration, termed a ‘ribocomputing’ strategy [78]. 
Green et al. implemented a complex logic system (combination of AND/OR/NOT) of 12 RNA inputs 
with five consecutive toehold switches colocalized in the same transcript. This 12-input logic circuit 
in E. coli provided evidence that a ribocomputing strategy could help in scaling up synthetic 
biological circuits in the future [79]. At the same time, novel RNA tools where translation is 
inactivated by trigger RNAs are also being explored. These include toehold repressor, three-way 
junction (3WJ) repressor, and looped antisense oligonucleotide, which enable a more complex and 
versatile logic with universal NAND and NOR gates [80,81]. 
In a similar vein, Lucks et al. engineered the natural antisense RNA-mediated transcriptional 
attenuation mechanism of plasmid pT181, and they proposed an RNA toolkit that could turn off 
transcription [28]. Based on this, Takahashi and Lucks demonstrated that more diverse orthogonal 
transcriptional regulators could be designed by combining the module with natural antisense RNA 
regulators [82]. Building on these works, Chappell et al. devised a novel transcription regulatory 
system, termed the ‘small transcription activating RNA’ (STAR), which promoted transcription upon 
cognate trigger RNA binding [83] (Figure 6A). The natural mechanism was utilized in an opposite 
manner such that the complementary STAR RNA disrupted the transcription terminator structure of 
the target gene. In their first demonstration of the STAR system, the fold change ranged from 3- to 
94-fold. In a subsequent work, they further optimized various domain lengths of STAR RNA through 
computational designs to create a STAR library with a broad fold activation range, from more than 
400-fold to less than 10-fold, to allow for more sophisticated biological circuit designs [84]. 
A platform for plant pathogen detection was demonstrated using the STAR system [85] (Figure 
6B). Verosloff et al. amplified viral DNA with the T7 RNAP promoter and an upstream STAR 
sequence by using recombinase polymerase amplification (RPA) with a primer that bound to a 
specific sequence of viral DNA. When viral RNA with the STAR sequence was transcribed by cell-
free expression, the reporter RNA started normal transcription of catechol 2,3-dioxygenase (CDO) in 
the tube, which caused a colorimetric change in the sample observable with the naked eye. In 
particular, this system has the advantage that both the RPA and the cell-free expression steps are 
conducted isothermally using only body heat as a heat source. 
 
Figure 6. Small transcription activating RNA (STAR) system and application for detecting plant 
pathogens. (A) Mechanism of STAR. A transcription terminator consists of a stem-loop and a poly-U 
track, where the binding of STAR RNA breaks the step-loop structure such that transcription proceeds 
normally. (B) A platform to diagnose plant pathogens using STAR. Viral RNA in the sample can be 
amplified with the addition of a STAR sequence and a promoter through recombinase polymerase 
amplification (RPA). Then, the corresponding RNA transcribed through cell-free expression induces 
the expression of reporter gene (CDO, catechol 2,3-dioxygenase). RNAP: T7 RNA polymerase. 
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A number of other works also demonstrated the utility of synthetic RNA regulatory parts for 
building synthetic biological circuits. Well-established anti-sense RNA (asRNA) could be utilized for 
translation regulation through binding at the 5′ untranslated region (UTR) and the start codon of the 
target mRNA [86]. Through analysis of the difference in repression of asRNA sequences, the 
repression was further enhanced by introducing the Hfq binding sequence into the asRNA [87]. 
Meanwhile, Rodrigo and Jaramillo developed a computational design tool, named ‘AutoBioCAD’, 
that allowed automatic RNA circuit design using secondary structure design and free energy analysis 
[88,89]. These RNA regulatory toolkits can contribute to the growing repertoire of cell-free synthetic 
biology applications including point-of-care devices for biomedical applications. 
5. Encapsulation of in Vitro Circuits toward the Synthesis of Artificial Cells 
In vitro synthetic biology has recently made progress towards realizing minimal cell systems. A 
key step toward this is the encapsulation of gene expression or TXTL systems in microscopic 
compartments. It has been demonstrated that both the kinetics and noise levels of chemical reactions 
are different in bulk than in cell-sized compartments or molecularly crowded solutions [90,91]. Thus, 
working with encapsulated synthetic biology components may improve our understanding of native 
cellular systems and how to emulate cell processes in synthetic systems [16]. Minimal cell systems 
can be designed to perform specified tasks autonomously, or they can network with native cells to 
increase sensing and actuation of biological systems. As encapsulation offers a barrier between 
critical components in synthetic circuits and surrounding environments, it is an essential step for 
designing effective minimal cell systems. 
Both water-in-oil droplets and vesicles have been used to encapsulate gene expression systems 
in sizes relevant to cells (roughly 1–50 μm in diameter). Water-in-oil droplets have been 
demonstrated to be biocompatible, stable at high temperatures, and capable of withstanding 
deformation [92]. The oil medium surrounding the droplets greatly limits molecular exchange 
between individual droplets, effectively creating isolated, independent, cell-sized reaction chambers. 
Microfluidics can produce hundreds or thousands of uniformly sized droplets a minute, while 
shaken droplet protocols result in droplets of varying sizes. 
Liposomes or vesicles more closely resemble native cells than water-in-oil droplets, but they are 
non-trivial to produce at cell sizes. Because the environment surrounding the vesicles is aqueous, 
exchange of biological molecules between the vesicles and the environment is possible for membrane-
permeable molecules as well as membrane-impermeable molecules in the presence of surface pores 
or channels [93–95]. Emulsion transfer, thin-film hydration, and microfluidics have been shown to 
effectively encapsulate TXTL systems in vesicles [90,96–100]. Emulsion transfer and microfluidics 
allow for finer control of the vesicle size and contents than thin-film hydration techniques [100]. 
Early encapsulation of expression systems characterized the production of single reporter 
proteins in bulk and in vesicles. Noireaux and Libchaber reported that expression of GFP in both 
vesicles and bulk solution had similar durations and produced similar outputs [90] (Figure 7A). They 
showed that by expressing a GFP-labeled α-hemolysin pore, expression was increased by one order 
of magnitude. The toxin α-hemolysin acts as a pore in lipid bilayers with a molecular mass cutoff of 
3 kDa, which allows nutrients from a surrounding feeding solution to enter the vesicle. Tan et al. 
demonstrated that vesicles protected an encapsulated GFP expression system from RNase A in the 
aqueous medium surrounding the droplet, which inhibited gene expression via degrading RNA 
[101]. 
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Figure 7. Synthetic gene circuits in cell-sized compartments. (A) (left) Expression of eGFP in bulk 
(open circles) and in a vesicle (closed dark circles), and expression of α-hemolysin-eGFP (closed green 
circles). (Inset) an expanded view of the first 20 h. (right) Fluorescence microscopy images of α-
hemolysin-eGFP expressed in vesicles. Scale bar: 10 μm. Reproduced with permission from [16]. (B) 
Superimposed false-color images of cyan fluorescent protein (CFP) and yellow florescent protein 
(YFP) expressed in droplets without (left) or with (right) Ficoll. In the presence of Ficoll, the expression 
level is highly variable across the population of droplets. Reproduced with permission from [102]. (C) 
Microscopy images of mYPet expression inside an aqueous two-phase system (ATPS) water-in-oil 
droplets. The images of transmitted light, fluorescence microscopy of mYPet, and fluorescence 
microscopy of Alexa 647-labeled dextran are presented, from left to right. mYPet is preferentially 
expressed in the dextran phase rather than the polyethylene glycol (PEG) phase. Scale bar: 25 μm. 
Reproduced with permission from [103]. 
Actualization of more complex gene expression systems, such as oscillators and cascading gene 
circuits, have subsequently been described in compartments [97,104]. In cascading reactions, 
products of an initial transcription system are necessary for further TXTL processes in the circuit. 
Garamella et al. encapsulated both five- and six-gene cascading circuits within vesicles [22]. They 
reported both an increase in the average expression across a population of 20–30 vesicles as well as 
an increase in the variability of expression for individual vesicles within the population for the six-
gene circuit compared to the five-gene circuit. Adamala et al. reported that higher-order cascading 
circuits in vesicles produced similar amounts of protein to bulk reactions containing the same volume 
[105]. They observed smaller vesicles than the work by Garamella and colleagues, using mammalian 
HeLa cell extracts, and their circuits were triggered by diffusion of doxycycline through α-hemolysin 
pores in the membranes of the vesicles. The average expression for the population of vesicles 
containing a three-gene cascading circuit produced less fLuc than vesicles containing either one- or 
two-gene cascading circuits. The encapsulated three-gene circuit did, however, produce similar 
amounts of fLuc to a bulk solution with the same reaction volume, while the encapsulated one- and 
two-gene circuits produced less than the corresponding bulk reactions. Both reports noted that the 
high variability in expression for the higher-order circuits likely was due to nonuniform 
encapsulation of the individual components of the circuit throughout the population of vesicles. This 
phenomenon has been described in other works, and it even affects lower-order genetic circuits such 
as simple transcription of eGFP [106]. 
In addition to studying the effects of compartmentalization on TXTL systems, the influence of 
molecular crowding on encapsulated systems is relevant for both minimal cell design and 
understanding native cell processes. The crowded interiors of cells have been shown to influence 
intracellular reaction rates [107]. Hansen et al. investigated the relationship among stochasticity of 
expression within water-in-oil droplets, concentration of genes, and concentration of crowding 
molecules [102]. They reported that introduction of the crowding molecule Ficoll 70 resulted in 
microenvironments of cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) within 
the droplets for the duration of expression (Figure 7B). They concluded that the microenvironments 
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formed because the rate of mRNA production was greater than the diffusion rate of the 
macromolecules involved in TXTL, as CFP and YFP diffused evenly through the droplets after the 
expression completed. They also noted that decreasing the available copies of gene within the 
expression system further increased the stochasticity of expression across the population of droplets. 
Tan et al. reported the effects of crowding molecules on minimal gene expression systems in vesicles, 
noting that crowding due to large dextran polymers increased expression of GFP in larger vesicles, 
while it had little effect on expression in smaller vesicles [101]. 
Molecular crowding not only affects reaction rates within cell-sized compartments but also leads 
to crowding-induced phase separation, which is another area of interest for synthetic biology efforts 
[108,109]. Liquid phase separation is a form of membrane-less partitioning, which occurs in native 
cell structures such as nucleoli and centrosomes, and is influenced by temperature, pH, 
concentration, and other factors [110]. Torre et al. showed confined expression of mYPet, a fluorescent 
protein, within a single phase of an aqueous two-phase system (ATPS) [103] (Figure 7C). The ATPS 
was a result of introducing both polyethylene glycol (PEG) and dextran to water-in-oil droplets, 
which separated into distinct PEG- and dextran-rich phases within the droplet. Torre et al. 
hypothesized that confinement of the gene expression to the dextran phases was a result of TXTL 
machinery partitioning the less hydrophobic dextran phase of the droplet. They reported no 
expression in encapsulated aqueous three-phase systems, suggesting this was due to splitting of the 
TXTL components between the dextran and Ficoll phases within the droplets. 
As the complexity of artificial cells increased, so too has the exploration of communication 
between networks made of artificial and native cells [50,111–114]. After showing that two distinct 
liposome-based minimal cells in a shared environment could respond to the same trigger without 
crosstalk, Adamala et al. demonstrated cascading networks of synthetic minimal cells as well as 
fusion-controlled TXTL systems [105] (Figure 8A). They realized a cascading expression system in 
which products from one vesicle that contained bacterial TX machinery triggered a response in a 
separate vesicle that contained mammalian TL machinery. Their work demonstrated that 
encapsulating TXTL systems provided modularity, allowing for interaction between otherwise 
incompatible components. Lentini et al. increased the sensing capacity of E. coli through networking 
with a synthetic translator cell [115] (Figure 8B). They induced expression of GFP within E. coli by 
creating an artificial cell that produced a chemical signal familiar to the bacteria, isopropyl β-D-1-
thiogalactopyranoside (IPTG), in response to theophylline (Theo), which was otherwise undetectable 
to the native cell. 
The exploration of artificial TXTL systems in cell-sized compartments is necessary for realizing 
artificial cells and fully understanding intracellular processes in confined and crowded 
environments. A number of complex gene expression circuits have been demonstrated in cell-sized 
compartments; however, the variety of components available for design—lipid bilayer vesicles vs 
water-in-oil droplets, bacterial vs mammalian cell-extracts, and so on—makes direct comparison 
between different studies difficult. The often encountered high variability in component 
concentrations during encapsulation processes may be alleviated through further exploration of 
encapsulation methods, fusion, and intercompartment exchange processes. Through 
compartmentalization, previously incompatible natural or synthetic systems in bulk solution can be 
interconnected as modular components, which paves the way for increasing the complexity of cell-
free synthetic circuits and coordination with native cells. 
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Figure 8. Interconnecting artificial and natural cells. (A) (left) Schematic design of synthetic sensor 
and reporter liposome pair, which contain bacterial and mammalian TXTL machinery, respectively. 
α-hemolysin (aHL) produced by theophylline treatment in the sensor liposome releases internal 
doxycycline to the environment, which in turn triggers expression of fLuc in the reporter liposome. 
(right) Expression of fLuc in different ratios of sensor and reporter liposomes. Occupancy refers to 
the ratio of droplets that contain TXTL machinery for both sensor and reporter droplets. Reproduced 
with permission from [105]. (B) (left) Flow cytometry data for E. coli containing a plasmid for GFP in 
the presence of the following components: theophylline (Theo), artificial cells (AC), artificial cells with 
theophylline (AC + Theo), isopropyl β-D-1-thiogalactopyranoside (IPTG) encapsulated in vesicles 
(Encapsulated IPTG), and IPTG in the bulk solution (IPTG). (right) Histogram of flow cytometry data 
shown in the left panel. Fluorescent signal is only increased in the presence of artificial cells and 
theophylline. Reproduced with permission from [115]. 
6. Artificial DNA Structures and Systems for in Vitro Synthetic Biology 
Because of its predictable self-assembly properties, DNA has been used to build versatile 
molecular machines and structures [116,117]. Complementary Watson–Crick base pairing between 
segments of synthetically designed DNA strands is utilized for the rational design of these static and 
dynamic devices, which can function autonomously by processing information obtained from its 
surroundings. DNA systems and circuits can present properties comparable to devices naturally 
found in the living cell, for example, it is possible to build DNA nanotubes with size and mechanical 
properties comparable to cytoskeletal filaments, DNA nanopores that dock on lipid bilayers with 
selective permeability, and transcriptional oscillators that could serve as clocks in synthetic cells 
[40,48,118,119]. DNA nanostructures could serve as physical components such as scaffolds, pores, 
and transport elements in artificial cells. Nucleic acid strand displacement reactions could be used to 
build sensors and signaling pathways [66,120–122]. Yet, these synthetic DNA systems may have 
difficulty in achieving desired structural integrity and functionality in the cellular environment since 
DNA nanostructures and networks have been typically characterized in buffer conditions very 
different from the complex environment of a cell. Therefore, it becomes a necessity to explore 
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synthetic DNA systems in cell lysates, serum, and cell-free extracts to develop design rules for proper 
operation in complex cellular environments and to realize their full potential as programmable 
components for in vitro and in vivo synthetic biology. 
The presence of cytoplasmic enzymes can affect the structural stability of synthetic DNA 
systems. Kuem et al. measured the half-life of tetrahedral DNA nanostructures (TDNs) in the 
presence of DNase I and found that the stability of TDNs was more than twice that of double-
stranded DNA [123] (Figure 9A). Castro et al. incubated DNA origami structures in the presence of 
different nucleases—DNase I, T7 endonuclease I, T7 exonuclease, E. coli exonuclease I, lambda 
exonuclease, and MseI restriction endonuclease [124]. Only DNase I and T7 endonuclease I were 
found to degrade the test origami structure, where the DNA origami structure could withstand 
complete degradation for 2 h in the presence of DNase I in contrast to the duplex plasmid DNA that 
disappeared within 5 min (Figure 9B). The interconnectivity and dense packing of the DNA 
nanostructures rendered some resistance to degradation by nucleases. 
Another cell-like medium in which to characterize synthetic DNA systems can be cell lysates—
the mixtures containing cellular components created by breaking down the membranes of cells. Mei 
et al. tested the stability of DNA origamis in cell lysate and reported that single- and double-stranded 
nucleic acids could not be recovered, whereas DNA origami could be recovered after up to 12 h [125]. 
However, the physiological relevance of this particular study was damped by the fact that cell lysate 
used sodium dodecyl sulfate (SDS) and deoxycholic acid (DCA), which suppressed many cellular 
enzymes. Therefore, a more physiological cell lysate preparation should be used for better assessing 
synthetic DNA systems in cell-like media. 
 
Figure 9. Characterization of DNA structures in cell-like media. (A) Denaturing polyacrylamide gel 
electrophoresis (PAGE) of tetrahedron and duplex DNAs with nonspecific degradation by DNase I. 
Digestion of the unligated tetrahedron is gradual and appears to generate a well-defined product, 
whereas digestion of linear DNA appears to be rapid and nonspecific. Reproduced with permission 
from [123]. (B) Stability of honeycomb-packed DNA nanostructure: 140 nm (18-helix bundle), 100 nm 
(24-helix bundle), and 70 nm (32-helix bundle), from left to right, were used for stability screening 
with TEM and agarose gel electrophoresis. Scale bar = 20 nm. Reproduced with permission from [124]. 
(C) Enhanced stability of DNA nanotubes with χ-site integration and chemical modifications in E. coli 
TXTL system. Fluorescence microscopy images of five-base DNA nanotubes with ligation of tile sticky 
ends and eight-base DNA nanotubes with phosphorothioate-bonded tile sticky ends incubated in 
TXTL with and without χ-site DNA present. Scale bar = 20 μm. Reproduced with permission from 
[126]. 
A useful platform for rapid characterization of synthetic components is the E. coli cell-free TXTL 
system. TXTL reiterates the physiological conditions found in cells as well as harsh linear DNA 
degradation through the RecBCD complex. Klocke et al. tested the stability of tile-based DNA 
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nanostructures in the TXTL system, demonstrating that the stability of structures increased 
significantly in the presence of χ-site double-stranded DNA, which was an inhibitor of the RecBCD 
complex [126] (Figure 9C). With the addition of 10 μM χ-sequences, tile-based nanotubes assembled 
from ligated DNA strands were stable in TXTL for more than 10 h. Further, phosphorothioation of 
the strands within nanotubes extended their viability in TXTL for more than 10 h without, and 24 h 
with, χ-sequences. However, chemically modified strands in DNA structures can introduce toxicity 
or trigger unwanted immune responses when introduced in cells [127]. Thus, chemical modifications 
should consider potential trade-offs of structural stability and cell toxicity. 
A number of studies were carried out to test the stability of DNA systems in serum and serum-
supplemented media. The Sleiman group tested the stability of DNA assemblies in 10% fetal bovine 
serum (FBS) [128]. They reported that individual strands had a half-life of less than one hour, whereas 
the half-life of DNA structures in the shape of a triangular prism was closer to two hours. Hahn et al. 
tested the stability of DNA origamis in mammalian cell culture media supplemented with serum, 
and they indicated that DNA nanostructures were sensitive to depletion of Mg2+ in tissue culture 
medium [129] (Figure 10A). Interestingly, structural stability was significantly enhanced with the 
addition of actin, a protein that competitively binds to nucleases. No observable differences in cell 
growth, viability, or phenotype were present when actin was included in the medium. 
The functionality of synthetic DNA circuitry is an important goal to achieve in the cellular 
environment. This spurred a number of studies on DNA circuitry in serum and serum-supplemented 
media. Goltry et al. investigated topological influences on the lifetimes of DNA devices using a three-
state DNA tweezer nanomachine and a two-state linear probe in human serum and FBS [130] (Figure 
10B). Degradation analysis revealed that the mean lifetimes of both systems in human serum were 
roughly six times longer than those in FBS. They reported that the device lifetimes varied greatly with 
topology (i.e., circular vs linear) and molecular conformation (i.e., shape of the structure), potentially 
providing a simple design rule to program structural stability or fragility. Graugnard et al. tested an 
autocatalytic strand-displacement network, reported by Zhang and colleagues [131], in human serum 
and mouse serum [132]. With the addition of SDS to halt nuclease activity, the synthetic network was 
functional in serum with both DNA and RNA catalysts. Fern and Schulman investigated strategies 
to enable strand-displacement circuits to operate in 10% FBS [133] (Figure 10C). By inhibiting 
nuclease activity using actin protein, and by modifying DNA complexes with hairpin extensions on 
the 3′ ends of DNA strands, the half-life of DNA strands increased by 10-fold. Through these 
modifications, a multilayer cascade circuit was demonstrated that released a desired output strand 
with controlled kinetics with the aid of computational modeling. 
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Figure 10. Characterization of DNA structures and circuits in serum. (A) 3D model of DNA 
nanooctahedron (DNO), six-helix bundle nanotube (NT), and 24-helix nanorod (NR) (top). TEM 
images of nanostructures incubated in unmodified (middle) or Mg2+-adjusted (bottom) medium. 
Structural integrity is maintained for all three designs with additional Mg ion. Scale bar = 100 nm. 
Reproduced with permission from [129]. (B) (top) Three-state DNA nanomachine transitions between 
relaxed, closed, and open states with the addition of fuel strands and their complements. The two-
state linear probe transitions between bright and dark states upon hybridization of the dye-labeled 
probe strand, P, and the quencher-labeled strand, Q. (bottom) Mean lifetimes of the DNA 
nanomachines and linear probes show considerable differences in degradation rates. Reproduced 
with permission from [130]. (C) (top) Schematic of two-layer DNA cascade reaction. (bottom) 
Simulation results of a two-layer cascade with 5 bp toeholds using the fitted parameters and 
experimental measurements. Reproduced with permission from [133]. 
Taken together, densely packed and interconnected DNA nanostructures, such as DNA origami, 
are consistently more stable than structurally simple nucleic acid architectures in cell-like 
environments. Nucleases can be a primary cause for structural instability of synthetic DNA systems; 
however, other processes also need to be taken into consideration. For instance, nonspecific 
transcription by RNAP can produce transcripts that, in turn, can interact with DNA nanostructures, 
leading to disassembly via a toehold-mediated branch migration [134]. Thus, more systematic 
research is warranted to develop strategies that shield DNA systems from unintended crosstalk with 
biological components and that maintain integrity of devices within the cellular context. Use of actin 
or χ-sites as molecular decoys, structural modifications to increase interconnectivity, chemical 
modifications, and hairpin extensions are some of the strategies explored towards achieving better 
functionality of synthetic DNA systems. The improved design rules for DNA nanomachines and 
circuits may support the translation of devices operational in cell-free settings to the cellular 
environment. 
7. Mathematical Modeling Supports the Development and Analysis of in Vitro Systems 
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Mathematical modeling has contributed to the success of synthetic biology since its inception 
[1,2]. Models are helpful to support the design of synthetic systems and to explain quantitatively 
observed phenomena, which may be otherwise difficult to understand, especially when they include 
feedback loops. Validated models are also useful to make predictions and guide experiments, making 
it possible to save time and costly reagents. Ordinary differential equations (ODEs) are one of the 
simplest approaches to build mathematical models to describe kinetic systems. ODE models are 
particularly well-suited to capture systems operating at high copy numbers, so they are an excellent 
choice for in vitro synthetic biology. Because in an in vitro setting it is usually possible to collect a 
large amount of kinetic data in which experimental conditions are varied systematically, ODEs can 
be easily fitted to the data and yield solid estimates of various parameters that govern the kinetics. 
Many in vitro synthetic systems have been quantitatively modeled using ODEs that can be built 
systematically starting from a list of relevant chemical reactions. Transcriptional networks, for 
example, include synthetic genes (genelets), two enzymes, and mRNA species to create regulatory 
interconnections between genelets in a rational manner [39,48]. To formulate an ODE model that 
captures the kinetics of an inhibited genelet, the species to be considered are the template T (active 
and inactive), its DNA activator A, the RNA inhibitor rI, and RNAP and RNase H that control RNA 
production and degradation. RNA inhibitor is produced by a “source” template (S), whose 
concentration is constant. The active template TA produces an RNA output rO. The template and its 
activator are referred to as a “switch” (SW). The complete set of reactions associated with this system 
is shown in Figure 11A. Using the law of mass action, it is possible to write ODEs that describe the 
reaction kinetics. For example, the free template concentration T is converted to active template TA 
by binding to the activator A at rate constant kTA; in turn, the active template TA is converted back to 
the free template T when it interacts with the inhibitor rI, which displaces the activator at rate kTAI. As 
a consequence, we can immediately write the kinetics of the free template as: 
ௗ்
ௗ௧ = −𝑘்஺[𝑇][𝐴] + 𝑘்஺ூ[𝑇𝐴][𝑟𝐼] . (1) 
The ODEs for all other species can be derived with the same procedure. Because the total 
template concentration remains constant, then [𝑇𝐴] = [𝑇௧௢௧] − [𝑇], which means the model does not 
require a specific ODE for the kinetics of TA. For enzyme kinetics, it is possible to use the well-known 
Michaelis–Menten quasi-steady state approximation so that the available concentrations of RNAP 
and RNase H can be expressed with an analytical, static formula as a function of their substrate 
(Figure 11C). The complete ODE model is pictured in Figure 11D. This model can be fitted to kinetic 
data, and it reproduces the steady state input–output map of the inhibitable switch (the input is the 
concentration of source S, the output is the fraction of active switch) (Figure 11E). 
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Figure 11. Ordinary differential equation (ODE) models for design and characterization of in vitro 
synthetic systems. (A) Schematic of an inhibited transcriptional switch. (B) List of reactions describing 
a transcriptional switch that is inhibited by RNA transcribed by a source template S. (C) Mass 
conservation and Michaelis–Menten expressions allow a simplification of the ODEs. (D) ODEs 
describing the inhibited transcriptional switch. (E) Example data showing the input–output steady 
state curve mapping the concentration of inhibitor source to the output switch concentration, 
overlapped with simulated steady state data (solid lines). Reproduced with permission from [39]. (F) 
A bistable switch can be constructed by interconnecting two inhibitor switches. (G) Experimental data 
(left) compared to simulated trajectories (right) of the bistable switch. Reproduced with permission 
from [39]. (H) Example transcription regulator used to build a gene performing NAR. G indicates GFP 
and its qualitative ODE model. (I) The qualitative ODE model suggests that the NAR circuit operates 
better when using at least two transcription repressors in tandem. (J) Simulations of detailed 
mechanistic models reproduce experimental data well. Adapted with permission from [32]. 
More complex transcriptional networks can be modeled with the same approach by modularly 
composing the models of individual switches. For instance, an ODE model of a bistable switch 
(Figure 11F) could be immediately built by interconnecting the models of two inhibitable switches 
whose RNA outputs mutually inhibited transcription [39]. The models were augmented by taking 
into account undesired or putative reactions, such as transcription from inactive template T, and 
captured very well the kinetic experiments, as shown in Figure 11G. Similarly, Kim and Winfree 
developed [48] ODE models for different versions of a transcriptional oscillator, in which side 
reactions played a very important role. For example, the ability of the model to reproduce the 
oscillator kinetics (in particular the damping rate) was significantly improved by including 
incomplete degradation products that accumulated during the oscillator reaction and their potential 
interactions with activation and inhibition of the genelets. ODE models built using the law of mass 
action can be used to model genelets, molecular machines, and other molecular processes, and they 
can be used to computationally test the influence of new, modified, or unknown components on the 
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system [40,135]. To summarize, mechanistic ODE models are successful at recapitulating the dynamic 
behaviors of in vitro synthetic systems, and they can be easily expanded to include additional species 
or reactions. Yet, these models can become very large, even in systems with few desired interactions, 
and obtaining physically meaningful fitted estimates for the model parameters requires the inclusion 
of tight bounds. 
A phenomenological approach to building ODE models is advantageous in building models 
with few variables and parameters, which helps in obtaining more intuitive results on the behavior 
of the system under consideration. Rather than being built from a list of chemical reactions, 
phenomenological models rely on qualitative relationships between species. For example, the steady 
state behavior of the inhibitable genelet shown in Figure 11E could be modeled using a single ODE 
in which the source template could cause a decrease of active switch via a Hill-type function. Beyond 
transcriptional circuits, phenomenological models have been used for many synthetic systems built 
in vitro, including RNA regulator-based circuits [32,136,137]. Figure 11H shows the qualitative model 
for a transcription regulator that achieves negative autoregulation (NAR) [32]; the species in the 
equations are the concentrations of RNA (R) and GFP (G), whose productions decrease as the 
concentration of RNA (R) increases (self-inhibition). Using parameters from the literature, this simple 
model was used to compare the efficiency of one versus two tandem repressors, and it yielded the 
trajectories in Figure 11I that qualitatively agreed with the experimental data in Figure 11J. Although 
a detailed mechanistic model was required to quantitatively reproduce data (Figure 11J), the simple 
model provided useful insights on the system kinetics. 
Limited modeling efforts have been dedicated to compartmentalized cell-free circuits, largely 
because this research is still in its early stages. Encapsulation can introduce noise and stochastic 
phenomena even when operating with few components at high concentration. The operation of a 
transcriptional oscillator, for example, was significantly affected by partitioning noise when 
encapsulated in water-in-oil droplets [104]; a model combining ODEs and stochastic partitioning of 
components (following a Poisson process) was able to recapitulate the variability in the circuit 
dynamics. Stochastic simulations could improve our understanding of noise observed in recent 
works aimed at encapsulation in high-order synthetic circuits [105,111,138]. 
8. Concluding Remarks 
As synthetic biological systems have become larger and more complex, deciphering the intricate 
interaction of synthetic systems and biological entities becomes a challenging task. Cell-free synthetic 
biological approaches, with the aid of rapid progress in its scope, and toolkits may provide the right 
platform for rapid design–build–test cycles. New technological breakthroughs for synthetic biology, 
such as CRISPR-Cas systems, can also be elucidated in this simplified TXTL test bed [23]. The ease 
with which to program nucleic acids has dramatically accelerated the structural and functional 
complexity of nucleic acid-based molecular devices. These new developments encompass simplified 
synthetic model dynamical systems and nucleic acid nanostructures, as well as synthetic RNA 
regulatory components, which form the core of practical tools for biomedical applications. 
Compartmentalization for synthetic cells opens up ways for scientific inquiry and enhanced 
functionality through networks of synthetic and natural systems. Data-driven model building needs 
to guide the research and development towards complex synthetic systems with prescribed dynamics 
in the future. In the coming years, we anticipate that the utility of cell-free synthetic biology will 
rapidly expand the scope of biotechnology and synthetic biology, and it will provide innovative 
solutions in biomanufacturing therapeutics for biomedical applications and biologic products for 
industrial applications. 
Author Contributions: D.J., M.K., S.A., J.K., S.C., E.F., and J.K. summarized the data and wrote the paper. 
Funding: This work was partially supported by the U.S. Department of Energy under grant SC0010595, which 
paid for the salary of M.K. and S.A. 
Conflicts of Interest: The authors declare no conflict of interest. 
Methods and Protoc. 2019, 2, 39 20 of 25 
 
References 
1. Elowitz, M.B.; Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature. 2000, 403, 
335–338. 
2. Gardner, T.S.; Cantor, C.R.; Collins, J.J. Construction of a genetic toggle switch in Escherichia coli. Nature 
2000, 403, 339–342. 
3. Cameron, D.E.; Bashor, C.J.; Collins, J.J. A brief history of synthetic biology. Nat. Rev. Microbiol. 2014, 12, 
381–390. 
4. Nielsen, A.A.; Der, B.S.; Shin, J.; Vaidyanathan, P.; Paralanov, V.; Strychalski, E.A.; Ross, D.; Densmore, D.; 
Voigt, C.A. Genetic circuit design automation. Science 2016, 352, aac7341. 
5. Bhatia, S.P.; Smanski, M.J.; Voigt, C.A.; Densmore, D.M. Genetic Design via Combinatorial Constraint 
Specification. ACS Synth. Biol. 2017, 6, 2130–2135. 
6. Garenne, D.; Noireaux, V. Cell-free transcription-translation: Engineering biology from the nanometer to 
the millimeter scale. Curr. Opin. Biotechnol. 2019, 58, 19–27. 
7. Dudley, Q.M.; Karim, A.S.; Jewett, M.C. Cell-free metabolic engineering: Biomanufacturing beyond the cell. 
Biotechnol. J. 2015, 10, 69–82. 
8. Guo, W.; Sheng, J.; Feng, X. Mini-review: In vitro Metabolic Engineering for Biomanufacturing of High-
value Products. Comput. Struct. Biotechnol. J. 2017, 15, 161–167. 
9. Carlson, E.D.; Gan, R.; Hodgman, C.E.; Jewett, M.C. Cell-free protein synthesis: Applications come of age. 
Biotechnol. Adv. 2012, 30, 1185–1194. 
10. Shin, J.; Noireaux, V. An E. coli Cell-Free Expression Toolbox: Application to Synthetic Gene Circuits and 
Artificial Cells. ACS Synth. Biol. 2012, 1, 29–41. 
11. Noireaux, V.; Bar-Ziv, R.; Libchaber, A. Principles of cell-free genetic circuit assembly. Proc. Natl. Acad. Sci. 
USA 2003, 100, 12672–12677. 
12. Marshall, R.; Maxwell, C.S.; Collins, S.P.; Beisel, C.L.; Noireaux, V. Short DNA containing chi sites enhances 
DNA stability and gene expression in E. coli cell-free transcription-translation systems. Biotechnol. Bioeng. 
2017, 114, 2137–2141. 
13. Stiege, W.; Erdmann, V.A. The potentials of the in vitro protein biosynthesis system. J. Biotechnol. 1995, 41, 
81–90. 
14. Jewett, M.C.; Noireaux, V. Synthetic biology: Tailor-made genetic codes. Nat. Chem. 2016, 8, 291–292. 
15. Timm, A.C.; Shankles, P.G.; Foster, C.M.; Doktycz, M.J.; Retterer, S.T. Toward Microfluidic Reactors for 
Cell-Free Protein Synthesis at the Point-of-Care. Small 2016, 12, 810–817. 
16. Noireaux, V.; Maeda, Y.T.; Libchaber, A. Development of an artificial cell, from self-organization to 
computation and self-reproduction. Proc. Natl. Acad. Sci. USA 2011, 108, 3473–3480. 
17. Matveev, S.V.; Vinokurov, L.M.; Shaloiko, L.A.; Davies, C.; Matveeva, E.A.; Alakhov, Y.B. Effect of the ATP 
level on the overall protein biosynthesis rate in a wheat germ cell-free system. Biochim. Biophys. Acta 1996, 
1293, 207–212. 
18. Ge, X.; Luo, D.; Xu, J. Cell-Free Protein Expression under Macromolecular Crowding Conditions. PLoS ONE 
2011, 6, e28707. 
19. Siegal-Gaskins, D.; Tuza, Z.A.; Kim, J.; Noireaux, V.; Murray, R.M. Gene Circuit Performance 
Characterization and Resource Usage in a Cell-Free “Breadboard.” ACS Synth. Biol. 2014, 3, 416–425. 
20. Shimizu, Y.; Inoue, A.; Tomari, Y.; Suzuki, T.; Yokogawa, T.; Nishikawa, K.; Ueda, T. Cell-free translation 
reconstituted with purified components. Nat. Biotechnol. 2001, 19, 751–755. 
21. Pardee, K.; Green, A.A.; Ferrante, T.; Cameron, D.E.; DaleyKeyser, A.; Yin, P.; Collins, J.J. Paper-based 
Synthetic Gene Networks. Cell 2014, 159, 940–954. 
22. Garamella, J.; Marshall, R.; Rustad, M.; Noireaux, V. The All E. coli TX-TL Toolbox 2.0: A Platform for Cell-
Free Synthetic Biology. ACS Synth. Biol. 2016, 5, 344–355. 
23. Marshall, R.; Maxwell, C.S.; Collins, S.P.; Jacobsen, T.; Luo, M.L.; Begemann, M.B.; Gray, B.N.; January, E.; 
Singer, A.; He, Y.; et al. Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-
Free Transcription-Translation System. Mol. Cell 2018, 69, 146–157.e3. 
24. Chappell, J.; Jensen, K.; Freemont, P.S. Validation of an entirely in vitro approach for rapid prototyping of 
DNA regulatory elements for synthetic biology. Nucleic Acids Res. 2013, 41, 3471–3481. 
25. Sun, Z.Z.; Yeung, E.; Hayes, C.A.; Noireaux, V.; Murray, R.M. Linear DNA for rapid prototyping of 
synthetic biological circuits in an Escherichia coli based TX-TL cell-free system. ACS Synth. Biol. 2014, 3, 387–
397. 
Methods and Protoc. 2019, 2, 39 21 of 25 
 
26. Takahashi, M.K.; Chappell, J.; Hayes, C.A.; Sun, Z.Z.; Kim, J.; Singhal, V.; Spring, K.J.; Al-Khabouri, S.; Fall, 
C.P.; Noireaux, V.; et al. Rapidly characterizing the fast dynamics of RNA genetic circuitry with cell-free 
transcription-translation (TX-TL) systems. ACS Synth. Biol. 2015, 4, 503–515. 
27. Niederholtmeyer, H.; Sun, Z.Z.; Hori, Y.; Yeung, E.; Verpoorte, A.; Murray, R.M.; Maerkl, S.J. Rapid cell-
free forward engineering of novel genetic ring oscillators. eLife 2015, 4, e09771. 
28. Lucks, J.B.; Qi, L.; Mutalik, V.K.; Wang, D.; Arkin, A.P. Versatile RNA-sensing transcriptional regulators 
for engineering genetic networks. Proc. Natl. Acad. Sci. USA 2011, 108, 8617–8622. 
29. Chappell, J.; Takahashi, M.K.; Meyer, S.; Loughrey, D.; Watters, K.E.; Lucks, J. The centrality of RNA for 
engineering gene expression. Biotechnol. J. 2013, 8, 1379–1395. 
30. Rosenfeld, N.; Alon, U. Response Delays and the Structure of Transcription Networks. J. Mol. Biol. 2003, 
329, 645–654. 
31. Shen-Orr, S.S.; Milo, R.; Mangan, S.; Alon, U. Network motifs in the transcriptional regulation network of 
Escherichia coli. Nat. Genet. 2002, 31, 64–68. 
32. Hu, C.Y.; Takahashi, M.K.; Zhang, Y.; Lucks, J.B. Engineering a Functional Small RNA Negative 
Autoregulation Network with Model-Guided Design. ACS Synth. Biol. 2018, 7, 1507–1518. 
33. Shin, J.; Jardine, P.; Noireaux, V. Genome Replication, Synthesis, and Assembly of the Bacteriophage T7 in 
a Single Cell-Free Reaction. ACS Synth. Biol. 2012, 1, 408–413. 
34. Rustad, M.; Eastlund, A.; Jardine, P.; Noireaux, V. Cell-free TXTL synthesis of infectious bacteriophage T4 
in a single test tube reaction. Synth. Biol. 2018, 3, ysy002. 
35. Pardee, K.; Green, A.A.; Takahashi, M.K.; Braff, D.; Lambert, G.; Lee, J.W.; Ferrante, T.; Ma, D.; Donghia, 
N.; Fan, M.; et al. Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular 
Components. Cell 2016, 165, 1255–1266. 
36. Pardee, K.; Slomovic, S.; Nguyen, P.Q.; Lee, J.W.; Donghia, N.; Burrill, D.; Ferrante, T.; McSorley, F.R.; 
Furuta, Y.; Vernet, A.; et al. Portable, On-Demand Biomolecular Manufacturing. Cell 2016, 167, 248–259.e12. 
37. Schwarz-Schilling, M.; Kim, J.; Cuba, C.; Weitz, M.; Franco, E.; Simmel, F.C. Building a Synthetic 
Transcriptional Oscillator. Methods Mol. Biol. 2016, 1342, 185–199. 
38. Kim, J.; Hopfield, J.J.; Winfree, E. Neural network computation by in vitro transcriptional circuits. In 
Proceedings of the 17th International Conference on Neural Information Processing Systems: Vancouver, 
BC, Canada, 5–8 December 2005; pp. 681–688. 
39. Kim, J.; White, K.S.; Winfree, E. Construction of an in vitro bistable circuit from synthetic transcriptional 
switches. Mol. Syst. Biol. 2006, 2, 68. 
40. Franco, E.; Friedrichs, E.; Kim, J.; Jungmann, R.; Murray, R.; Winfree, E.; Simmel, F.C. Timing molecular 
motion and production with a synthetic transcriptional clock. Proc. Natl. Acad. Sci. USA 2011, 108, E784–
E793. 
41. Martin, C.T.; Coleman, J.E. Kinetic Analysis of T7 RNA Polymerase-Promoter Interactions with Small 
Synthetic Promoters. Biochemistry 1987, 26, 2690–2696. 
42. Subsoontorn, P.; Kim, J.; Winfree, E. Ensemble Bayesian Analysis of Bistability in a Synthetic 
Transcriptional Switch. ACS Synth. Biol. 2012, 1, 299–316. 
43. Yurke, B.; Mills, A.P., Jr. Using DNA to power nanostructures. Genet. Program. Evolvable Mach. 2003, 4, 111–
122. 
44. Markevich, N.I.; Hoek, J.B.; Kholodenko, B.N. Signaling switches and bistability arising from multisite 
phosphorylation in protein kinase cascades. J. Cell Biol. 2004, 164, 353–359. 
45. Ghaffarizadeh, A.; Flann, N.S.; Podgorski, G.J. Multistable switches and their role in cellular differentiation 
networks. BMC Bioinform. 2014, 15, S7. 
46. Proctor, C.J.; Gray, D.A. Explaining oscillations and variability in the p53-Mdm2 system. BMC Syst. Biol. 
2008, 2, 75. 
47. Nelson, D.E.; Ihekwaba, A.E.C.; Elliott, M.; Johnson, J.R.; Gibney, C.A.; Foreman, B.E.; Nelson, G.; See, V.; 
Horton, C.A.; Spiller, D.G.; et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression. 
Science 2004, 306, 704–708. 
48. Kim, J.; Winfree, E. Synthetic in vitro transcriptional oscillators. Mol. Syst. Biol. 2011, 7, 465. 
49. Cho, E.J.; Lee, J.-W.; Ellington, A.D. Applications of Aptamers as Sensors. Annu. Rev. Anal. Chem. 2009, 2, 
241–264. 
50. Dupin, A.; Simmel, F.C. Signalling and differentiation in emulsion-based multi-compartmentalized in vitro 
gene circuits. Nat. Chem. 2019, 11, 32–39. 
Methods and Protoc. 2019, 2, 39 22 of 25 
 
51. Lloyd, J.; Tran, C.H.; Wadhwani, K.; Cuba Samaniego, C.; Subramanian, H.K.K.; Franco, E. Dynamic 
Control of Aptamer-Ligand Activity Using Strand Displacement Reactions. ACS Synth. Biol. 2018, 7, 30–37. 
52. Kim, J.; Quijano, J.F.; Yeung, E.; Murray, R.M. Synthetic logic circuits using RNA aptamer against T7 RNA 
polymerase. bioRxiv 2014, doi:10.1101/008771. 
53. Cuba Samaniego, C.; Franco, E. A Robust Molecular Network Motif for Period-Doubling Devices. ACS 
Synth. Biol. 2018, 7, 75–85. 
54. Franco, E.; Giordano, G.; Forsberg, P.-O.; Murray, R.M.; Negative Autoregulation Matches Production and 
Demand in Synthetic Transcriptional Networks. ACS Synth. Biol. 2014, 3, 589–599. 
55. Kim, J.; Khetarpal, I.; Sen, S.; Murray, R.M. Synthetic circuit for exact adaptation and fold-change detection. 
Nucleic Acids Res. 2014, 42, 6078–6089. 
56. Cuba Samaniego, C.; Giordano, G.; Kim, J.; Blanchini, F.; Franco, E. Molecular Titration Promotes 
Oscillations and Bistability in Minimal Network Models with Monomeric Regulators. ACS Synth. Biol. 2016, 
5, 321–333. 
57. Ayukawa, S.; Takinoue, M.; Kiga, D. RTRACS: A Modularized RNA-Dependent RNA Transcription 
System with High Programmability. Acc. Chem. Res. 2011, 44, 1369–1379. 
58. Takinoue, M.; Kiga, D.; Shohda, K.-I.; Suyama, A. Experiments and simulation models of a basic 
computation element of an autonomous molecular computing system. Phys. Rev. E Stat. Nonlinear Soft 
Matter Phys. 2008, 78, 041921. 
59. Montagne, K.; Plasson, R.; Sakai, Y.; Fujii, T.; Rondelez, Y. Programming an in vitro DNA oscillator using 
a molecular networking strategy. Mol. Syst. Biol. 2011, 7, 466. 
60. Baccouche, A.; Montagne, K.; Padirac, A.; Fujii, T.; Rondelez, Y. Dynamic DNA-toolbox reaction circuits: A 
walkthrough. Methods 2014, 67, 234–249. 
61. Padirac, A.; Fujii, T.; Rondelez, Y. Bottom-up construction of in vitro switchable memories. Proc. Natl. Acad. 
Sci. USA 2012, 109, E3212–E3220. 
62. Fujii, T.; Rondelez, Y. Predator-prey molecular ecosystems. ACS Nano 2013, 7, 27–34. 
63. Zadorin, A.S.; Rondelez, Y.; Gines, G.; Dilhas, V.; Urtel, G.; Zambrano, A.; Galas, J.-C.; Estevez-Torres, A. 
Synthesis and materialization of a reaction–diffusion French flag pattern. Nat. Chem. 2017, 9, 990–996. 
64. Padirac, A.; Fujii, T.; Rondelez, Y. Quencher-free multiplexed monitoring of DNA reaction circuits. Nucleic 
Acids Res. 2012, 40, e118. 
65. Soloveichik, D.; Seelig, G.; Winfree, E. DNA as a universal substrate for chemical kinetics. Proc. Natl. Acad. 
Sci. USA 2010, 107, 5393–5398. 
66. Seelig, G.; Soloveichik, D.; Zhang, D.Y.; Winfree, E. Enzyme-Free Nucleic Acid Logic Circuits. Science 2006, 
314, 1585–1588. 
67. Qian, L.; Winfree, E. Scaling Up Digital Circuit Computation with DNA Strand Displacement Cascades. 
Science 2011, 332, 1196–1201. 
68. Qian, L.; Winfree, E.; Bruck, J. Neural network computation with DNA strand displacement cascades. 
Nature 2011, 475, 368–372. 
69. Cherry, K.M.; Qian, L. Scaling up molecular pattern recognition with DNA-based winner-take-all neural 
networks. Nature 2018, 559, 370–376. 
70. Srinivas, N.; Parkin, J.; Seelig, G.; Winfree, E.; Soloveichik, D. Enzyme-free nucleic acid dynamical systems. 
Science 2017, 358, eaal2052. 
71. Douglas, S.M.; Bachelet, I.; Church, G.M. A Logic-Gated Nanorobot for Targeted Transport of Molecular 
Payloads. Science 2012, 335, 831–834. 
72. Isaacs, F.J.; Dwyer, D.J.; Collins, J.J. RNA synthetic biology. Nat Biotechnol. 2006, 24, 545–554. 
73. Lease, R.A.; Belfort, M. A trans-acting RNA as a control switch in Escherichia coli: DsrA modulates function 
by forming alternative structures. Proc. Natl. Acad. Sci. USA 2000, 97, 9919–9924. 
74. Isaacs, F.J.; Dwyer, D.J.; Ding, C.; Pervouchine, D.D.; Cantor, C.R.; Collins, J.J. Engineered riboregulators 
enable post-transcriptional control of gene expression. Nat. Biotechnol. 2004, 22, 841–847. 
75. Green, A.A.; Silver, P.A.; Collins, J.J.; Yin, P. Toehold Switches: De-Novo-Designed Regulators of Gene 
Expression. Cell 2014, 159, 925–939. 
76. Ma, D.; Shen, L.; Wu, K.; Diehnelt, C.W.; Green, A.A. Low-cost detection of norovirus using paper-based 
cell-free systems and synbody-based viral enrichment. Synth. Biol. 2018, 3, ysy018. 
Methods and Protoc. 2019, 2, 39 23 of 25 
 
77. Takahashi, M.K.; Tan, X.; Dy, A.J.; Braff, D.; Akana, R.T.; Furuta, Y.; Donghia, N.; Ananthakrishnan, A.; 
Collins, J.J. A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host 
biomarkers. Nat. Commun. 2018, 9, 3347. 
78. Kim, J.; Yin, P.; Green, A.A. Ribocomputing: Cellular Logic Computation Using RNA Devices. Biochemistry 
2018, 57, 883–885. 
79. Green, A.A.; Kim, J.; Ma, D.; Silver, P.A.; Collins, J.J.; Yin, P. Complex cellular logic computation using 
ribocomputing devices. Nature 2017, 548, 117–121. 
80. Kim, J.; Zhou, Y.; Carlson, P.; Teichmann, M.; Simmel, F.C.; Silver, P.A.; Collins, J.J.; Lucks, J.B.; Yin, P.; 
Green, A.A. De-Novo-Designed Translational Repressors for Multi-Input Cellular Logic. bioRxiv 2018, 
doi:10.1101/501783. 
81. Carlson, P.D.; Glasscock, C.J.; Lucks, J.B. De novo Design of Translational RNA Repressors. bioRxiv 2018, 
doi:10.1101/501767. 
82. Takahashi, M.K.; Lucks, J.B. A modular strategy for engineering orthogonal chimeric RNA transcription 
regulators. Nucleic Acids Res. 2013, 41, 7577–7588. 
83. Chappell, J.; Takahashi, M.K.; Lucks, J.B. Creating small transcription activating RNAs. Nat. Chem. Biol. 
2015, 11, 214–220. 
84. Chappell, J.; Westbrook, A.; Verosloff, M.; Lucks, J.B. Computational design of small transcription 
activating RNAs for versatile and dynamic gene regulation. Nat. Commun. 2017, 8, 1051. 
85. Verosloff, M.; Chappell, J.; Perry, K.L.; Thompson, J.R.; Lucks, J.B. PLANT-Dx: A Molecular Diagnostic for 
Point of Use Detection of Plant Pathogens. ACS Synth. Biol. 2019, 8, 902-905. 
86. Hoynes-O’Connor, A.; Hinman, K.; Kirchner, L.; Moon, T.S. De novo design of heat-repressible RNA 
thermosensors in E. coli. Nucleic Acids Res. 2015, 43, 6166–6179. 
87. Lee, Y.J.; Moon, T.S. Design rules of synthetic non-coding RNAs in bacteria. Methods 2018, 143, 58–69. 
88. Rodrigo, G.; Jaramillo, A. AutoBioCAD: Full biodesign automation of genetic circuits. ACS Synth. Biol. 2013, 
2, 230–236. 
89. Rodrigo, G.; Landrain, T.E.; Jaramillo, A. De novo automated design of small RNA circuits for engineering 
synthetic riboregulation in living cells. Proc. Natl. Acad. Sci. USA 2012, 109, 15271–15276. 
90. Noireaux, V.; Libchaber, A. A vesicle bioreactor as a step toward an artificial cell assembly. Proc. Natl. Acad. 
Sci. USA 2004, 101, 17669–17674. 
91. Minton, A.P. The Influence of Macromolecular Crowding and Macromolecular Confinement on 
Biochemical Reactions in Physiological Media. J. Biol. Chem. 2001, 276, 10577–10580. 
92. Holtze, C.; Rowat, A.C.; Agresti, J.J.; Hutchison, J.B.; Angilè, F.E.; Schmitz, C.H.J.; Köster, S.; Duan, H.; 
Humphry, K.J.; Scanga, R.A.; et al. Biocompatible surfactants for water-in-fluorocarbon emulsions. Lab Chip 
2008, 8, 1632. 
93. Walter, A.; Gutknecht, J. Permeability of small nonelectrolytes through lipid bilayer membranes. J. Membr. 
Biol. 1986, 90, 207–217. 
94. Finkelstein, A. Water and nonelectrolyte permeability of lipid bilayer membranes. J. Gen. Physiol. 1976, 68, 
127–135. 
95. Wei, C.; Pohorille, A. Permeation of Membranes by Ribose and Its Diastereomers. J. Am. Chem. Soc. 2009, 
131, 10237–10245. 
96. Abkarian, M.; Loiseau, E.; Massiera, G. Continuous droplet interface crossing encapsulation (cDICE) for 
high throughput monodisperse vesicle design. Soft Matter 2011, 7, 4610. 
97. Ishikawa, K.; Sato, K.; Shima, Y.; Urabe, I.; Yomo, T. Expression of a cascading genetic network within 
liposomes. FEBS Lett. 2004, 576, 387–390. 
98. Ota, S.; Yoshizawa, S.; Takeuchi, S. Microfluidic Formation of Monodisperse, Cell-Sized, and Unilamellar 
Vesicles. Angew. Chem. 2009, 121, 6655–6659. 
99. Weiss, M.; Frohnmayer, J.P.; Benk, L.T.; Haller, B.; Janiesch, J.W.; Heitkamp, T.; Börsch, M.; Lira, R.B.; 
Dimova, R.; Lipowsky, R.; et al. Sequential bottom-up assembly of mechanically stabilized synthetic cells 
by microfluidics. Nat. Mater. 2018, 17, 89–96. 
100. Matosevic, S.; Paegel, B.M. Stepwise Synthesis of Giant Unilamellar Vesicles on a Microfluidic Assembly 
Line. J. Am. Chem. Soc. 2011, 133, 2798–2800. 
101. Tan, C.; Saurabh, S.; Bruchez, M.P.; Schwartz, R.; LeDuc, P. Molecular crowding shapes gene expression in 
synthetic cellular nanosystems. Nat. Nanotechnol. 2013, 8, 602–608. 
Methods and Protoc. 2019, 2, 39 24 of 25 
 
102. Hansen, M.M.; Meijer, L.H.; Spruijt, E.; Maas, R.J.; Rosquelles, M.V.; Groen, J.; Heus, H.A.; Huck, W.T.S. 
Macromolecular crowding creates heterogeneous environments of gene expression in picolitre droplets. 
Nat. Nanotechnol. 2016, 11, 191–197. 
103. Torre, P.; Keating, C.D.; Mansy, S.S. Multiphase Water-in-Oil Emulsion Droplets for Cell-Free 
Transcription–Translation. Langmuir 2014, 30, 5695–5699. 
104. Weitz, M.; Kim, J.; Kapsner, K.; Winfree, E.; Franco, E.; Simmel, F.C. Diversity in the dynamical behaviour 
of a compartmentalized programmable biochemical oscillator. Nat. Chem. 2014, 6, 295–302. 
105. Adamala, K.P.; Martin-Alarcon, D.A.; Guthrie-Honea, K.R.; Boyden, E.S. Engineering genetic circuit 
interactions within and between synthetic minimal cells. Nat. Chem. 2017, 9, 431–439. 
106. de Souza, T.P.; Fahr, A.; Luisi, P.L.; Stano, P. Spontaneous encapsulation and concentration of biological 
macromolecules in liposomes: An intriguing phenomenon and its relevance in origins of life. J. Mol. Evol. 
2014, 79, 179–92. 
107. Klumpp, S.; Scott, M.; Pedersen, S.; Hwa, T. Molecular crowding limits translation and cell growth. Proc. 
Natl. Acad. Sci. USA 2013, 110, 16754–16759. 
108. Albertsson, P.A. Partition of cell particles and macromolecules in polymer two-phase systems. Adv. Protein 
Chem. 1970, 24, 309–341. 
109. Aumiller Jr., W.M.; Keating, C.D. Experimental models for dynamic compartmentalization of biomolecules 
in liquid organelles: Reversible formation and partitioning in aqueous biphasic systems. Adv. Colloid 
Interface Sci. 2017, 239, 75–87. 
110. Hyman, A.A.; Weber, C.A.; Jülicher, F. Liquid-Liquid Phase Separation in Biology. Annu. Rev. Cell Dev. Biol. 
2014, 30, 39–58. 
111. Lentini, R.; Martín, N.Y.; Forlin, M.; Belmonte, L.; Fontana, J.; Cornella, M.; Martini, L.; Tamburini, S.; 
Bentley, W.E.; Jousson, O.; et al. Two-Way Chemical Communication between Artificial and Natural Cells. 
ACS Cent. Sci. 2017, 3, 117–123. 
112. Bayoumi, M.; Bayley, H.; Maglia, G.; Sapra, K.T. Multi-compartment encapsulation of communicating 
droplets and droplet networks in hydrogel as a model for artificial cells. Sci. Rep. 2017, 7, 45167. 
113. Elani, Y.; Trantidou, T.; Wylie, D.; Dekker, L.; Polizzi, K.; Law, R.V.; Ces, O. Constructing vesicle-based 
artificial cells with embedded living cells as organelle-like modules. Sci. Rep. 2018, 8, 4564. 
114. Rampioni, G.; Leoni, L.; Mavelli, F.; Damiano, L.; Stano, P. Interfacing Synthetic Cells with Biological Cells: 
An Application of the Synthetic Method. In Proceedings of the 2018 Conference on Artificial Life: A Hybrid 
of the European Conference on Artificial Life (ECAL) and the International Conference on the Synthesis 
and Simulation of Living Systems (ALIFE): Tokyo, Japan, 23-27 July 2018; pp. 145–146. 
115. Lentini, R.; Santero, S.P.; Chizzolini, F.; Cecchi, D.; Fontana, J.; Marchioretto, M.; Del Bianco, C.; Terrell, J.L.; 
Spencer, A.C.; Martini, L.; et al. Integrating artificial with natural cells to translate chemical messages that 
direct E. coli behaviour. Nat. Commun. 2014, 5, 4012. 
116. Bloomfield, V.A.; Crothers, D.M.; Tinoco, I.; Hearst, J.E.; Wemmer, D.E.; Killman, P.A.; Turner, D.H. Nucleic 
Acids: Structures, Properties, and Functions, 1st ed.; University Science Books: Sausalito, CA, USA, 2000; 627p. 
117. SantaLucia, J.; Hicks, D. The Thermodynamics of DNA Structural Motifs. Annu. Rev. Biophys. Biomol. Struct. 
2004, 33, 415–440. 
118. Rothemund, P.W.K.; Ekani-Nkodo, A.; Papadakis, N.; Kumar, A.; Fygenson, D.K.; Winfree, E. Design and 
Characterization of Programmable DNA Nanotubes. J. Am. Chem. Soc. 2004, 126, 16344–16352. 
119. Li, W.; Bell, N.A.W.; Hernández-Ainsa, S.; Thacker, V.V.; Thackray, A.M.; Bujdoso, R.; Keyser, U.F. Single 
Protein Molecule Detection by Glass Nanopores. ACS Nano 2013, 7, 4129–4134. 
120. Zhang, D.Y.; Seelig, G. Dynamic DNA nanotechnology using strand-displacement reactions. Nat. Chem. 
2011, 3, 103–113. 
121. Yurke, B.; Turberfield, A.J.; Mills Jr., A.P.; Simmel, F.C.; Neumann, J.L. A DNA-fuelled molecular machine 
made of DNA. Nature 2000, 406, 605–608. 
122. Dirks, R.M.; Pierce, N.A. Triggered amplification by hybridization chain reaction. Proc. Natl. Acad. Sci. USA 
2004, 101, 15275–15278. 
123. Keum, J.W.; Bermudez, H. Enhanced resistance of DNA nanostructures to enzymatic digestion. Chem. 
Commun. 2009, 7036–7038, doi:10.1039/b917661f. 
124. Castro, C.E.; Kilchherr, F.; Kim, D.N.; Shiao, E.L.; Wauer, T.; Wortmann, P.; Bathe, M.; Dietz, H. A primer 
to scaffolded DNA origami. Nat. Methods 2011, 8, 221–229. 
Methods and Protoc. 2019, 2, 39 25 of 25 
 
125. Mei, Q.; Wei, X.; Su, F.; Liu, Y.; Youngbull, C.; Johnson, R.; Lindsay, S.; Yan, H.; Meldrum, D. Stability of 
DNA Origami Nanoarrays in Cell Lysate. Nano Lett. 2011, 11, 1477–1482. 
126. Klocke, M.A.; Garamella, J.; Subramanian, H.K.K.; Noireaux, V.; Franco, E. Engineering DNA nanotubes 
for resilience in an E. coli TXTL system. Synth. Biol. 2018, 3, ysy001. 
127. Bramsen, J.B.; Laursen, M.B.; Nielsen, A.F.; Hansen, T.B.; Bus, C.; Langkjær, N.; Babu, B.R.; Højland, T.; 
Abramov, M.; Van Aerschot, A.; et al. A large-scale chemical modification screen identifies design rules to 
generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res. 2009, 37, 2867–2881. 
128. Conway, J.W.; McLaughlin, C.K.; Castor, K.J.; Sleiman, H. DNA nanostructure serum stability: Greater than 
the sum of its parts. Chem. Commun. 2013, 49, 1172. 
129. Hahn, J.; Wickham, S.F.J.; Shih, W.M.; Perrault, S.D. Addressing the Instability of DNA Nanostructures in 
Tissue Culture. ACS Nano 2014, 8, 8765–8775. 
130. Goltry, S.; Hallstrom, N.; Clark, T.; Kuang, W.; Lee, J.; Jorcyk, C.; Knowlton, W.B.; Yurke, B.; Hughes, W.L.; 
Graugnard, E. DNA topology influences molecular machine lifetime in human serum. Nanoscale 2015, 7, 
10382–10390. 
131. Zhang, D.Y.; Turberfield, A.J.; Yurke, B.; Winfree, E. Engineering Entropy-Driven Reactions and Networks 
Catalyzed by DNA. Science 2007, 318, 1121–1125. 
132. Graugnard, E.; Cox, A.; Lee, J.; Jorcyk, C.; Yurke, B.; Hughes, W.L. Operation of a DNA-Based Autocatalytic 
Network in Serum. In Proceedings of the 16th International Conference on DNA Computing and Molecular 
Programming, Hong Kong, China, 14–17 June 2010; pp. 83–88. 
133. Fern, J.; Schulman, R. Design and Characterization of DNA Strand-Displacement Circuits in Serum-
Supplemented Cell Medium. ACS Synth. Biol. 2017, 6, 1774–1783. 
134. Schaffter, S.W.; Green, L.N.; Schneider, J.; Subramanian, H.K.K.; Schulman, R.; Franco, E. T7 RNA 
polymerase non-specifically transcribes and induces disassembly of DNA nanostructures. Nucleic Acids 
Res. 2018, 46, 5332–5343. 
135. Montagne, K.; Gines, G.; Fujii, T.; Rondelez, Y. Boosting functionality of synthetic DNA circuits with 
tailored deactivation. Nat. Commun. 2016, 7, 13474. 
136. Westbrook, A.; Tang, X.; Marshall, R.; Maxwell, C.S.; Chappell, J.; Agrawal, D.K.; Dunlop, M.J.; Noireaux, 
V.; Beisel, C.L.; Lucks, J.; et al. Distinct timescales of RNA regulators enable the construction of a genetic 
pulse generator. Biotechnol. Bioeng. 2019, 116, 1139–1151. 
137. Hu, C.Y.; Varner, J.D.; Lucks, J.B. Generating Effective Models and Parameters for RNA Genetic Circuits. 
ACS Synth. Biol. 2015, 4, 914–926. 
138. Joesaar, A.; Yang, S.; Bogels, B.; van der Linden, A.; Pieters, P.; Kumar, B.V.V.S.P.; Dalchau, N.; Phillips, A.; 
Mann, S.; de Greef, T.F.A. Distributed DNA-based Communication in Populations of Synthetic Protocells. 
Nat. Nanotechnol. 2019, 14, 369–378. 
 
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
  
